Tirzepatide, found in Mounjaro and Zepbound, mimics both GIP and GLP-1 hormones to activate insulin production. Semaglutide, ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Share on Pinterest Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) drug. You inject the drug into your stomach, thigh, or upper arm.

According to their findings, semaglutide led to a "significant" reduction in overall heart weight, cardiomyocyte area, and mass in the left ventricle in both lean and obese mice. The same test was ...

Another drug, Zepbound, also contains the same ... doses into the same area of your body, such as your thigh. But try to use different injection sites that are a few inches apart to avoid ...

Note: The FDA has recently approved Zepbound to help with ... injection site reactions. You can inject Mounjaro into your abdomen, the top of your thigh, or the back of your upper arm.

Eli Lilly and Co. reported that its FDA-approved weight-loss drug Zepbound (tirzepatide) outperformed Novo Nordisk A/S’s Wegovy (semaglutide) in the phase IIIb Surmount-5 trial.

Today, GLP-1 drugs, including Wegovy, Mounjaro and Zepbound, have become household names and key tools in the fight against obesity: 1 in 8 American adults say they have used a GLP-1 drug ...

A New York aesthetician was arrested on Wednesday for allegedly buying counterfeit Botox from China and injecting it into patients, without the required license, according to the U.S. Attorney's ...

None of the counterfeit drugs were approved by the FDA, prosecutors said. A New York aesthetician was arrested on Wednesday for allegedly buying counterfeit Botox from China and injecting it into ...